Prelude Therapeutics Incorporated (PRLD)
USD 0.91
(2.18%)
USD 0.91
(2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -107.06 Million | -83.72 Million | -83.53 Million | -46.17 Million | -25.66 Million | -12.95 Million |
| Net Income | -121.83 Million | -115.43 Million | -111.69 Million | -56.92 Million | -27.57 Million | -14.68 Million |
| Depreciation & Amortization | 1.16 Million | 1.32 Million | 915 Thousand | 542 Thousand | 382 Thousand | 149 Thousand |
| Deferred income taxes | -3.47 Million | - | 1.36 Million | - | - | - |
| Stock-based compensation | 25.61 Thousand | 25.14 Million | 20.93 Million | 5.58 Million | 846 Thousand | 180 Thousand |
| Change in working capital | -10.47 Million | 932 Thousand | 3.62 Million | 4.61 Million | 667 Thousand | 1.38 Million |
| Other non-cash items | 1.93 Million | 4.3 Million | 1.32 Million | 11 Thousand | 10 Thousand | 15 Thousand |
| Investing Cash Flow | -34.64 Million | 81.69 Million | -263.8 Million | -621 Thousand | -780 Thousand | -529 Thousand |
| Investments in PPE | -3.51 Million | -3.01 Million | -2.32 Million | -621 Thousand | -780 Thousand | -529 Thousand |
| Acquisitions | 31.13 Thousand | -84.71 Thousand | - | - | - | - |
| Investment purchases | -221.63 Million | -119.22 Million | -261.48 Million | - | - | - |
| Sales/Maturities of investments | 190.5 Million | 203.93 Million | - | - | - | - |
| Other Investing Activities | -31.13 Thousand | 84.71 Thousand | -261.48 Thousand | - | - | - |
| Financing Cash Flow | 136.39 Million | 815 Thousand | 164.89 Million | 246.22 Million | 29.72 Million | 17.93 Million |
| Debt repayment | - | - | - | -258 Thousand | -124 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -17.00 | - | - | - | - | - |
| Common Stock Issuance | 135.73 Million | 389 Thousand | 161.42 Million | 166.63 Million | 29.85 Million | 17.93 Million |
| Other Financing Activities | 664 Thousand | 426 Thousand | 3.47 Million | 79.85 Million | 29.72 Thousand | 17.93 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.27 Million | -347 Thousand | 3.9 Million | 1.15 Million | 546 Thousand | 721 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -8.2 Million | 1.27 Million | -278 Thousand | 3.45 Million | 121 Thousand | 661 Thousand |
| Cash at beginning of period | 34.64 Million | 35.87 Million | 218.3 Million | 18.87 Million | 15.59 Million | 11.14 Million |
| Cash at end of period | 29.33 Million | 34.64 Million | 35.87 Million | 218.3 Million | 18.87 Million | 15.59 Million |
| Capital Expenditure | -3.51 Million | -3.01 Million | -2.32 Million | -621 Thousand | -780 Thousand | -529 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.31 Million | -1.22 Million | -182.43 Million | 199.43 Million | 3.28 Million | 4.45 Million |
| Free Cash Flow | -110.57 Million | -86.74 Million | -85.85 Million | -46.79 Million | -26.44 Million | -13.48 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -34.74 Million | -31.43 Million | -121.83 Million | -33.07 Million | -30.6 Million | -30.43 Million |
| Depreciation & Amortization | 452 Thousand | 426 Thousand | 1.16 Million | 331 Thousand | 279 Thousand | 281 Thousand |
| Deferred income taxes | - | - | -3.47 Million | -1.07 Million | -1.59 Million | -359 Thousand |
| Stock-based compensation | 6098.00 | 5.54 Million | 25.61 Million | 5.91 Million | 6.71 Million | 6.73 Million |
| Change in working capital | 6.06 Million | -5.2 Million | -10.47 Million | 3.71 Million | -926 Thousand | -4.33 Million |
| Other non-cash items | 4.99 Million | 4.64 Million | 1.93 Million | 608 Thousand | 454 Thousand | 442 Thousand |
| Investing Cash Flow | 26.11 Million | 31.22 Million | -34.64 Million | 7.73 Million | 15.04 Million | -75.42 Million |
| Investments in PPE | -359 Thousand | -289 Thousand | -3.51 Million | -1.12 Million | -591 Thousand | -983 Thousand |
| Acquisitions | - | - | 31.13 Thousand | -8865.00 | -15.63 Thousand | 74.44 Thousand |
| Investment purchases | -7.88 Million | -5.49 Million | -221.63 Million | -59.38 Million | -34.11 Million | -120.94 Million |
| Sales/Maturities of investments | 34.36 Million | 37 Million | 190.5 Million | 68.25 Million | 49.75 Million | 46.5 Million |
| Other Investing Activities | 26.47 Thousand | 31.51 Thousand | -31.13 Thousand | 8865.00 | 15.63 Thousand | -74.44 Thousand |
| Financing Cash Flow | 59 Thousand | -14 Thousand | 136.39 Million | 25.23 Million | 88 Thousand | 111.33 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -18.00 | -16.00 | -17.00 | -1.00 | -16.00 | - |
| Common Stock Issuance | 173 Thousand | 2000.00 | 135.73 Million | 24.93 Million | 104 Thousand | 111.33 Million |
| Other Financing Activities | -114 Thousand | -16 Thousand | 664 Thousand | 301 Thousand | -15.98 Thousand | 111.33 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.07 Million | 631 Thousand | -2.27 Million | -465 Thousand | -472 Thousand | -1.7 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.99 Million | -5.83 Million | -8.2 Million | 4.18 Million | -454 Thousand | -2.62 Million |
| Cash at beginning of period | 24.7 Million | 25.29 Million | 34.64 Million | 19.94 Million | 30.49 Million | 22.24 Million |
| Cash at end of period | 27.82 Million | 24.7 Million | 29.33 Million | 29.33 Million | 19.94 Million | 30.49 Million |
| Capital Expenditure | -359 Thousand | -289 Thousand | -3.51 Million | -1.12 Million | -591 Thousand | -983 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.12 Million | -584 Thousand | -5.31 Million | 9.39 Million | -10.55 Million | 8.24 Million |
| Free Cash Flow | -23.41 Million | -32.08 Million | -110.57 Million | -24.7 Million | -26.27 Million | -28.65 Million |
DUOL
DOV
000582
GEECEE
JAGRAN
CRRX